Colon and Rectal Surgery for Inflammatory Bowel Disease Patients on Vedolizumab: Preliminary Surgical Outcomes
Background and Objectives: Vedolizumab is an antagonist of leukocyte trafficking that targets gut α4β7 integrins and is efficacious in inflammatory bowel disease (IBD). Studies investigating postoperative complications in patients on this medication have not been performed. The objective of this stu...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Medknow Publications
2018-01-01
|
| Seri Bilgileri: | World Journal of Colorectal Surgery |
| Konular: | |
| Online Erişim: | https://journals.lww.com/10.4103/1941-8213.240252 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|